Bio Path Holdings Inc (BPTH)

[Snug9]

SJ, looks like smoke and mirrors to me! PN referred to the protocol change as a “minor adjustment to the protocol”. I think the adjustment means that the phase II dosing is going to have to be completed “again” before any meaningful results are accomplished, I’m guessing another year “at least”. The financials indicate that we have $4mil in the bank and the burn rate is about $1mil per qtr but that should increase significantly with all of the programs Peter referred to that are underway. There’s not enough money to finish anything without additional funding and Peter’s put BPTH in a position that future funding will come at a huge cost to both BPTH and the long-term investors.
He started by saying that BPTH is in a great position to start helping patients. What? If that was his concern this product would have been in the market years ago and we would be reaping the rewards of our investments!
By the way, ARWR is receiving funding from Amgen which may be why their market cap is so large compared to a nothing company like BPTH.